Charlottesville, VA, United States of America

Boris P Kovatchev

USPTO Granted Patents = 49 (Patent Applications = 34)

CIPO Patents = 10 (Patent Applications = 8)

EPO Patents = 19 (Patent Applications = 37)

Average Co-Inventor Count = 2.7

ph-index = 14

Forward Citations = 1,681(Granted Patents)

Location History:

Amherst, VA (US) (2004 - 2012)
Padua, IT (2021)
Charlottesville, VA (US) (2010 - 2024)

Company Filing History:

46 out of 997

University of Virginia Patent Foundation

patents

8 out of 1,353

Abbott Diabetes Care Inc.

patents

where one patent can have more than one assignee

Years Active: 2004-2025

Loading Chart...

49 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12362838 - Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors (2025-07-15),

2. 12324682 - Unified platform for monitoring and control of blood glucose levels in diabetic patients (2025-06-10),

3. 12285589 - Insulin monitoring and delivery system and method for CGM based fault detection and mitigation via metabolic state tracking (2025-04-29),

4. 12266436 - Method and system for the safety, analysis and supervision of insulin pump action and other modes of insulin delivery in diabetes (2025-04-01),

5. 12178571 - Method, system and computer program product for CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery (2024-12-31),

6. 11986294 - Method, system and computer program product for CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery (2024-05-21),

7. 11957463 - Accuracy of continuous glucose sensors (2024-04-16),

8. 11951278 - Insulin monitoring and delivery system and method for CGM based fault detection and mitigation via metabolic state tracking (2024-04-09),

9. 11901079 - System, method and computer readable medium for dynamical tracking of the risk for hypoglycemia in type 1 and type 2 diabetes (2024-02-13),

10. 11842817 - Tracking changes in average glycemia in diabetics (2023-12-12),

11. 11751779 - Method, system and computer program product for CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery (2023-09-12),

12. 11723562 - Method, system and computer program product for CGM-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery (2023-08-15),

13. 11722229 - Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors (2023-08-08),

14. 11567062 - System and method for tracking changes in average glycemia in diabetics (2023-01-31),

15. 11355238 - Method, system and computer program product for evaluation of blood glucose variability in diabetes from self-monitoring data (2022-06-07),

Title: Innovator Spotlight: Boris P Kovatchev - Pioneering Advances in Diabetes Care

Introduction: Boris P Kovatchev, a distinguished innovator in diabetes care, hails from Charlottesville, VA. With an impressive portfolio of 43 patents, his groundbreaking work has significantly impacted the field of healthcare technology.

Latest Patents: One of his latest patents involves a cutting-edge method, system, and computer program product for Continuous Glucose Monitoring (CGM)-based prevention of hypoglycemia. This innovation focuses on assessing the risk of hypoglycemia for patients and making informed decisions to prevent it effectively. Additionally, Kovatchev's work includes enhancing the accuracy of Continuous Glucose Sensors (CGS) devices, showcasing his commitment to improving diabetes management technologies.

Career Highlights: Boris P Kovatchev has made substantial contributions while working with renowned institutions such as the University of Virginia Patent Foundation and Abbott Diabetes Care Inc. His expertise and dedication have led to the development of innovative solutions that have the potential to revolutionize diabetes care globally.

Collaborations: Throughout his career, Kovatchev has collaborated with industry experts such as Marc D Breton and Stephen D Patek. These collaborations have been instrumental in driving forward cutting-edge research and development initiatives in the healthcare technology sector.

Conclusion: Boris P Kovatchev's contributions to the field of diabetes care underscore his unwavering commitment to innovation and improving patient outcomes. His pioneering work continues to inspire advancements in the healthcare industry, setting new standards for excellence in diabetes management technologies.

.

This text is generated by artificial intelligence and may not be accurate.